Lucy Day

CFO

Chief Accounting Officer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ANTX

Current role

CFO, Chief Accounting Officer

2023-09-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	AN2 Therapeutics, Inc. (ANTX)	Chief Financial Officer	$447,200	—	$52,545	$88,211	$178,880	$7,500	$774,336
2024	AN2 Therapeutics, Inc. (ANTX)	Chief Financial Officer	$447,200	—	$82,500	$141,339	$134,160	$7,500	$812,699
2023	AN2 Therapeutics, Inc. (ANTX)	Chief Financial Officer	$430,000	—	—	$888,058	$206,400	—	$1,524,458
2022	AN2 Therapeutics, Inc. (ANTX)	Chief Financial Officer	$379,934	—	—	$811,893	$136,776	—	$1,328,603

No earnings-call appearances or filed executive changes recorded yet.